The aim of the CASTEL, a population-based (n ‫؍‬ 3282) prospective study which began 14 years ago, was to identify those items which had a prognostic impact in the elderly, and to evaluate whether the typical cardiovascular risk factors, particularly arterial hypertension, play a role after the age of 65 years. Initial screening, final follow-up and annual detection of mortality were performed. Mantel-Hanszel approach and multivariate Cox model were used for statistics. Cardiovascular mortality was 23.3% in normotensive, 23.3% in borderline, and 25% in the sustained hypertensive subjects (insignificant difference). In women, the incidence of stroke and coronary artery disease weakly depended on pulse pressure. Historical stroke and myocardial infarction predicted cardiovascular mortality in women; diabetes, uricaemia and high heart rate in men. In the very old, the predictors were less numerous, and blood pressure was not a predictor whatsoever; pulse blood
Introduction
Many risk factors for cardiovascular risk, including arterial hypertension, have been identified in middleaged adults. However, very little is known about elderly people. Only a few trials have enrolled elderly subjects as part of the recruited population, [1] [2] [3] [4] [5] [6] but their power of analysis was quite limited, owing to the small number of elderly subjects that were included. A limited number of trials were specifically designed for the elderly, [7] [8] [9] [10] [11] [12] [13] and many of them, [11] [12] [13] [14] [15] were intervention trials on elderly hypertensives rather than epidemiological studies. Representative data on risk factors for cardiovascular disease in the elderly are therefore lacking. The CArdiovascular STudy in the Elderly (CASTEL) was conceived with the aim of evaluating the prevalence of hypertension in people aged 65 years or over and to identify the cardiovascular risk factors still operating in elderly subjects from the general population. The 14-year final results are described herein.
Materials and methods

Data recording
The CASTEL is a population-based, prospective study in which 3282 subjects aged у65 years have been enrolled, representing 73% of all elderly subjects from the northern Italian towns of Castelfranco and Chioggia (Veneto Region). Out of all the people contacted, 27% refused to participate or did not respond whatsoever and were, consequently, not included in the cohort or considered for calculation of mortality.
The protocol of the study was previously published elsewhere. 16 Briefly, an initial screening and a follow-up including morbidity were carried out, and mortality was monitored over a period of 14
Journal of Human Hypertension years. During the initial screening (1983) (1984) (1985) and at the follow-up, heart rate and sphygmomanometric supine blood pressure (BP) were measured in triplicate at 15-min intervals, repeating this procedure three times at 1-month intervals; the average of the last two of the nine measurements was taken into consideration.
Historical data were recorded by means of a questionnaire. Body mass index was calculated as the weight/squared height ratio. All subjects underwent blood exams and were screened for albuminuria with a dipstick using a random morning urine sample. Maximal expiratory flow in 1 second was measured, and reference values individually calculated. 17 In a randomly chosen subset (n ϭ 504), left ventricular mass was calculated in end-diastole from 1.04·[(diameter + posterior wall + septum) 3 − diameter 3 ] − 13.6 and indexed to body surface area. 18 The general characteristics of this random sample were not different from those of the entire population (data not shown).
Causes of death were double-checked with hospital or general practitioners' files. The frequency of non-fatal morbid events was recorded both at the initial screening and at the end of follow-up.
Definitions
Cut-off values for categorical items and diagnostic criteria of disease are summarised in Table 1 . Twenty-one presumptive predictors of cardiovascular mortality (age, gender, arterial hypertension, chronic obstructive pulmonary disease, uric acid, proteinuria, body mass index, impaired glucose tolerance, total and high-density lipoprotein (HDL) cholesterol, triglycerides, heart rate, haematocrit, history of heart failure, MI, stroke, murmurs at the neck, cigarette smoking, left ventricular hypertrophy, coffee and alcohol consumption) were played as independent variables in stepwise Cox models for overall and cardiovascular mortality, fatal MI, fatal heart failure and fatal stroke. The analysis was then repeated using pulse pressure instead of hypertension. The aim of this procedure was to avoid those confounding variables that could obscure the influence of BP on mortality. The interaction sex × pulse pressure was also included in another Cox analysis. Both gender and its interaction were significant (see below), indicating that pulse pressure had a different impact on survival in males and females; the multivariate model was therefore repeated, including the same variables listed above but sex, in the two genders separately.
Antihypertensive treatment, when present, was stopped 15 days before BP measurement, then-as usual in population studies-started again when necessary; 71% of men and 73% of women so received antihypertensive medication before the end of the follow-up. As antihypertensive medication could influence the outcome, antihypertensive therapy as a dichotomic covariate was included in the multivariate Cox analysis to adjust the results for this item.
As previously described elsewhere, 19 655 subjects -screened from the general population in the frame of a clinical trial-were randomly assigned to special care (decided and conducted by a hypertension unit) or to free therapy (decided and conducted by general practitioners). The two groups differed in that, those belonging to the hypertension unit underwent assiduous BP control, advice concerning lifestyle and answers to any questions concerning personal health problems, while those pertaining the free therapy were followed by their physician who spontaneously prescribed a treatment and were simply observed during the following 14 years by the CASTEL task force. BP reduction and 14-year cardiovascular mortality were compared in the two groups, and the type of therapy (free, special) was included as a dichotomic covariate in Cox analysis of cardiovascular risk. In a long-lasting epidemiological study, it is inevitable that any hypertensive patient (HT) on treatment have their therapy changed (particularly in the simply observational groups) and that some subjects shift from the category of normotension to that of hypertension or vice versa. Although it is difficult to establish what effect these points had on the relationship between BP and cardiovascular mortality in the CASTEL, one can speculate that they probably tend to annul each other in the long term. A non-population-based experimental protocol (namely a pure randomised clinical trial without any observational branch) would be necessary to bypass this problem, but this was not the aim of the CASTEL.
Data analysis was then repeated after excluding subjects having cardiovascular disease (n ϭ 490) and those dying within the first 2 years of screening (n ϭ 163). The aim of this procedure was to avoid the confounding effect of seriously ill subjects who could show during the follow-up a trend towards low BP values and/or an altered relationship between BP and mortality.
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Results
Cross-sectional study
Mean age at entry was 73.8 ± 5.3 years (range 65-91), 73.1 ± 4.8 in the 1281 males and 74.2 ± 5.5 in the 2001 females (P Ͻ 0.0001). In the five quintiles of age (656 subjects each) mean age was 67.5 ± 1.2, 70.4 ± 0.8, 73 ± 1.1, 76 ± 1.4 and 82 ± 3.2 years, respectively (all P Ͻ 0.0001 vs each others). The last quintile (77-95 years of age), corresponded to the current definition of the very old.
In the whole cohort, BP was 159.8 ± 24.7/88.7 ± 11.5 mm Hg. In the five quintiles of age it was 157.3 ± 25.1/90.1 ± 11 † ‡, 159.6 ± 24.4/89.5 ± 11.6, 161 ± 24.9*/89.5 ± 11.5 † ‡, 160.7 ± 23.9/87.5 ± 11.7 ‡, and 159.9 ± 24.8/86.9 ± 11.4, respectively (*P Ͻ 0.01 vs 1st, †P Ͻ 0.001 vs 4th, ‡P Ͻ 0.001 vs 5th quintiles).
The normotensive (NT) subjects totalled 451, the borderline HT 1001 (30.5%) and the sustained HT 1830 (55.8%). BP was 156.8 ± 24 mm Hg in males and 161.8 ± 24.9 mm Hg in females (P Ͻ 0.0001), heart rate 73.5 ± 11.5 and 77.6 ± 11.2 bpm, respectively (P Ͻ 0.0001). The general characteristics of the NT, borderline and sustained HT subjects are shown in Table 2 .
Of the 795 subjects (288 males, 507 females) who had impaired glucose tolerance, 543 were diabetic (16.5% of the whole cohort).
The general characteristics of the very old people are summarised in Table 3 .
Follow-up and morbid events
Both systolic and diastolic BP values measured at the end of follow-up were on average 8.8% lower than at the initial screening, and the prevalence of hypertension was also lower (Table 4) .
Non-fatal morbid events are summarised in Table 5 . Only the incidence of non-fatal coronary artery disease (MI or angina) and heart failure was greater in the hypertensives.
Overall mortality
At the 14th year, 1616 subjects had died and 1666 were still alive (mortality rate 49.2%, 56% in males, 44.9% in females; P Ͻ 0.0001; RR male gender 1.31 (1.17 Ϭ 1.48). Overall mortality in relation to hypertension and to hypercholesterolaemia is shown in Figure 1 . Overall mortality rate was 45.4% in normoglycaemic subjects, 60.5% in those with non-diabetic glucose intolerance (P Ͻ 0.0001), and 61.5% in the diabetics (P Ͻ 0.0001 vs normoglycaemic).
Cardiovascular mortality
Death was cardiovascular in 24.3% of cases (Table 5) ; when the 490 subjects with cardiovascular disease at screening were excluded from the analysis, the rate was 22.1% 
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Role of gender:
Gender was accepted as a predictive item in a preliminary Cox analysis carried out on the entire population (RR of male gender 1.29; 1.12 Ϭ 1.48). Consequently, the Cox analysis was repeated for the two genders separately. Twelve items (Table 6 ) turned out to be independently predictive in men and eight in women, while the others-including arterial hypertension in both genders-were rejected from the equation.
Role of BP: Cardiovascular mortality was 23.3% both in normotensive and borderline subjects, and 25% in sustained hypertensive patients (an insignificant difference). Figure 1 shows the cumulative mortality through the follow-up. Hypertension as a categorical item, as well as systolic, diastolic, mean and pulse BP as continuous items after logarithmic transformation, were rejected from the equations of cardiovascular risk. As mentioned above, the inter- ). Numbers in brackets denote 95% confidence intervals. action gender × pulse pressure was significant for fatal stroke and MI ( 2 3.54, P Ͻ 0.05, and 2 2.26, P Ͻ 0.05, respectively). In women, but not in men, pulse pressure was accepted in the Cox model for stroke and MI ( 2 14.1, P Ͻ 0.0005, and 2 3.90, P Ͻ 0.05, respectively) and the incidence of these two items steadily increased with increasing pulse pressure (Figure 2) . RR of the 5th quintile (mean pulse pressure 100 ± 12 mm Hg) for fatal stroke was 1.65 (1.12 Ϭ 2.44) and that for fatal MI 1.32
Journal of Human Hypertension (1.08 Ϭ 1.61) in comparison to the 1st quintile (mean pulse pressure 46 ± 10 mm Hg). Other predictors of fatal stroke were age, uricaemia, and historical stroke, other predictors of fatal MI were age, uricaemia, diabetes, historical coronary disease and stroke.
Role of antihypertensive treatment:
When the entire elderly population was taken into consideration, antihypertensive treatment was not predictive of cardiovascular mortality (Cox coeff. 0.15 ± 0.07, insignificant). After considering selectively the 655 hypertensive patients chosen for to the randomised intervention trial, type of therapy was accepted as a multivariate predictive item ( 2 13.1, P Ͻ 0.0001; RR of free therapy 1.37 (1.06 Ϭ 1.76), although the BP reduction obtained after treatment was similar in the two groups (Figure 3) .
Role of reduced glucose tolerance:
Diabetic patients had a cardiovascular mortality rate of 33.5% (RR 1.55; 1.30 Ϭ 1.87) and those with borderline glucose intolerance 31.3% (RR 1.48; 1.15 Ϭ 1.91); both rates were significantly higher (P Ͻ 0.005) than that of the normoglycaemics (21.5%). The trend of cardiovascular mortality in relation to blood glucose was J-shaped in men, while in women mortality was significantly higher only in the 5th quintile, ie, that including diabetic patients (Figure 4) . Diabetes also was a multivariate predictor of fatal MI and fatal heart failure ( 2 26.3, P Ͻ 0.0001, and 2 6.1, P Ͻ 0.05, respectively).
Role of lipids:
Blood lipids were rejected from all the Cox analyses. Cardiovascular, coronary, stroke and heart failure mortality were similar in normoand hypercholesterolemic subjects (Figure 1 ).
Role of uric acid:
Cardiovascular mortality was 21.6% in subjects with normal uric acid and 31% in those with a level Ͼ6 mg/dl (P Ͻ 0.0001; RR 1.21;
1.14 Ϭ 1.46). Uricaemia also predicted fatal occurrence of MI, stroke and heart failure ( 2 9.5, P Ͻ 0.01; 2 5.6, P Ͻ 0.05; and 2 8.3, P Ͻ 0.005, respectively). A J-shaped trend of cardiovascular mortality in relation to uric acid was found in women ( Figure 4) . Role of chronic pulmonary disease: Cardiovascular mortality was 22% among subjects without and 28% among those with chronic pulmonary disease (P Ͻ 0.0001; RR 1.32; 1.14 Ϭ 1.53; ie, 1.39; 1.10 Ϭ 1.76 in males and 1.24; 1.01 Ϭ 1.50 in females).
Role of proteinuria: Cardiovascular mortality was 24% in non-proteinuric subjects, 22.5% in those
Journal of Human Hypertension Figure 4 Fourteen-year cardiovascular mortality rate in relation to blood glucose and serum uric acid levels in both genders.
with traces (NS), and 31% in those with frank proteinuria (P Ͻ 0.005 vs the other two categories, RR of frank proteinuria 1.31; 1.01 Ϭ 1.72).
Role of historical items:
History of angina pectoris, MI, stroke and heart failure strongly predicted cardiovascular mortality in the multivariate analysis (Table 6 ). Historical MI also predicted the incidence of fatal MI, historical heart failure that of fatal heart failure, and historical stroke that of fatal stroke ( 2 24.4, P Ͻ 0.0001; 2 6.5, P Ͻ 0.01; and 2 26.4, P Ͻ 0.05, respectively). Murmurs at the neck predicted both cardiovascular mortality (Table 6 ) and the incidence of fatal stroke ( 2 26.4, P Ͻ 0.0001).
Role of left ventricular hypertrophy:
Electrocardiographic left ventricular hypertrophy was accepted in the Cox equation of cardiovascular risk in both genders ( The seriously ill subjects: Exclusion of seriously ill subjects having cardiovascular disease at screening did not change substantially the results (data not shown in details).
Journal of Human Hypertension
Discussion
Representative data on the prevalence and importance of cardiovascular risk factors in the elderly are difficult to find in literature simply because few of the studies conducted in the past were specifically designed to answer this question. 20, 21 However, as cardiovascular disease remains the commonest cause of mortality in persons over the age of 65 years, it is important to identify the risk factors are still operative in the elderly.
Hypertension is generally considered to be a major contributor of cardiovascular disease in middle-aged subjects. Although the common opinion is that it continues to play a prognostic role in the elderly too, [22] [23] [24] the cardiovascular risk ratios for hypertension are known to diminish with advancing age 20, 21, 25 and some authors consider hypertension nothing more than a weak predictor-or not a predictor at all-over the age of 65 years. [26] [27] [28] [29] We agree with this latter opinion, but only in part. On one hand, the label of hypertension was not a predictor of cardiovascular mortality in the CAS-TEL: in Figure 1 , the cumulative survival curves of normotensive, borderline and sustained hypertensive subjects were overlapping, without any statistical difference, and hypertension was constantly rejected from all the Cox equations of survival. On the other hand, incidence of angina pectoris and heart failure was greater in the hypertensives when compared to the normotensives (Table 5) , and-at least in women-incidence of fatal stroke and MI increased with increasing pulse pressure (Figure 4) .
Pulse pressure (a correlate of pulsatile haemodynamic load) is one of the indices of arterial stiffness 30 and the best predictor of the development of intima-media thickening (ie of the resistance vessels structural adaptation). 31 A disproportionate increase in systolic over diastolic pressure-with a consequent notable rise in the pulsatile component -is commonly observed in old people, 31, 32 which in the past lead to the belief that high pulse pressure could be a quasi-normal finding in the aged. This hypothesis has recently been disputed, based on the observation that pulse pressure predicts cardiovascular accidents. 30, 33, 34 Actually, in our survey, only pulse pressure was a predictor of cardiovascular mortality. The reason why this happened in women and not in men remains unknown; one possibility is that the large artery stiffnessreflected by pulse pressure-occurs differently in men and women, being the stiffening kept low before the menopause. 35 Consequently, enrolling coeval men and women, we actually managed males biologically older than females.
High BP therefore maintains a negative prognostic potential in the elderly, although its value appears not to be as definite as in the younger age group. Simply, the currently used classification of hypertension in three categories (normotensive, borderline and sustained HT subjects) appears inadequate for describing the prognosis of elderly subjects. This does not mean that antihypertensive treatment is superfluous in the elderly. On the contrary, many authors demonstrated an improvement of outcome in elderly hypertensive patients receiving an effective medication, in comparison to those who were untreated or treated less actively. 14, 15 This is not in contrast with the here reported results showing a limited prognostic importance of arterial hypertension in the elderly: the beneficial effects of antihypertensive therapy could simply be due to accessory pharmacological actions of drugs, independent of BP lowering. 36 The results of our randomised trial are in keeping with this hypothesis. When the whole population, including NT subjects and HT patients, was considered, antihypertensive treatment did not influence mortality and was rejected from the Cox equations of risk. On the other hand, when HT subjects were selectively taken into consideration, those on special therapy were advantaged as cardiovascular survival was concerned. As BP reduction was comparable in free therapy and special care groups (Figure 3) , it is clear that special care led to an improvement of survival independently of BP control. It has been speculated that some drugs are not only efficacious antihypertensive agents in the elderly, but also appear promising-due to ancillary properties-in counteracting some of the cardiovascular and renal consequences of hypertension. 37, 38 Similarly, it has been recently demonstrated that the HMG-CoA reductase inhibitors can reduce mortality or morbidity, or improve the clinical picture, independent on their cholesterol-lowering effects. [39] [40] [41] Consequently, the effectiveness of antihypertensive or antihyperlipidaemic treatment in the elderly should not be considered tout court as a 'gold standard' for establishing that hypertension and hypercholesterolaemia maintain their negative potential in this age class. In any case, a recent metanalisis including the CASTEL as well as the Systolic Hypertension in the Elderly Program (SHEP), 42 the Swedish Trial in Old Patients with Hypertension (STOP), 43 the Syst-Eur and the study by Coope and Warrender 44 has also shown that the effectiveness of antihypertensive treatment is less evident after the age of 80 years; 45 this is in keeping with the belief that the importance of hypertension as a risk factor is progressively decreasing with increasing age.
Other risk factors or indicators were better predictors of cardiovascular mortality than hypertension or hypercholesterolaemia. Uricaemia was one of the most important. A possible prognostic value of this item has been emphasised in recent years in European and Chinese population, 46, 47 although sometimes denied. 48, 49 Apart that many hypertensive, obese, diabetic and nephropatic subjects are hyperuricaemic, uric acid is known to correlate with total peripheral resistance, acting as an independent indicator of cardiovascular disease. The reason why, in our experience, the mortality curve was sometimes J-shaped ( Figure 4 ) is unclear; it can be postulated that subjects with the lowest uric acid levels have a reduced muscular mass and are probably undernourished and disadvantaged in terms of survival. The negative Cox coefficient of body mass index (Table 6) , indicating a worse survival in thin subjects, probably has the same meaning. 50 As in other studies, [51] [52] [53] glucose intolerance had a comparable prognostic impact, increasing the risk of cardiovascular mortality by a factor of ෂ1.5. At variance with the Seven Countries Study, 53 this prognostic role was still present among the very old, at least in men.
In recent years tachycardia has been shown to be independently associated to a risk of death in males, [54] [55] [56] but very little is known in this respect in the elderly. According to the literature and to a recent study carried out by our group in a subset of the CASTEL, 57 heart rate strongly predicted cardiovascular mortality in males but not in females.
Pulse rate is a marker of underlying haemodynamic and metabolic abnormalities, but the common belief is that by itself it can also turn out to be protective when low, and detrimental when high. In our survey, heart rate kept its prognostic value even after correction for these confounders. The fast heart rate is an indicator of increased sympathetic tone, which may disadvantage survival. 57 Another possibility is that it reflects a lower level of physical fitness, a lower cardiac reserve or subclinical forms of cardiovascular disease.
Cardiovascular mortality was predicted by electrocardiographic left ventricular hypertrophy, whose prognostic role in men was even greater than that of diabetes. On the contrary, left ventricular mass was not a predictor. It is known that electrocardiographic and echocardiographic left ventricular hypertrophy reflect two different approaches. The former depends on the electric activity of myocardial fibres (which increase with the pressor load), the latter on the myocardial mass (which can simply increase with growing old due to an accumulation of electrically-inactive connective tissue 58 ). Consequently, in the elderly heart weight detected with echocardiogram has a prognostic value related to that of age, and it is not surprising that it does not predict mortality after correction for age. Furthermore, the echocardiographic formulas and cut-off values for left ventricular hypertrophy are not adequately validated in the elderly, and their aptitude in detecting the real hypertrophy is questionable.
Proteinuria is a very common finding in our populations, its frequency increasing with advancing age even in the absence of renal disease. 59 In the study described herein, proteinuria-a clear predictor in men-was not simply a complication of hypertension as suggested by others. 60 In fact, the two conditions were associated only in a limited number of cases (Table 2) ; the former increased during the folJournal of Human Hypertension low-up while the latter decreased (Table 4) , and proteinuria was accepted in the Cox analysis while hypertension was rejected. Proteinuria was, therefore, an independent predictor.
A reduced pulmonary function also was a predictor of great importance. Other authors 61 have demonstrated-but not at a population level-that forced expiratory volume is the one of the most important independent predictors of survival in the elderly. Now, while it can be difficult to measure this parameter in the population screenings or in clinical practice, physical symptoms such as dyspnea, cough, or catarrh represent simple and cheap historical prognostic indices that should always be taken into consideration when calculating the cardiovascular risk of elderly persons.
Serum triglycerides were accepted in the Cox equations in males only. We are therefore unable to confirm the opinion of La Rosa et al 62 that triglycerides are strong predictors of cardiovascular risk in elderly females.
Other items were devoid of any prognostic role. Cardiovascular mortality was not enhanced by hypercholesterolaemia; as in other studies, 52, 63, 64 lower cholesterol levels were even associated with shorter, rather than longer, overall survival ( Figure 1 ). Once more, inappropriate nutrition could be an explanation for this finding. On the contrary, we reject the hypothesis that hypocholesterolaemic subjects with cancer died prematurely, leading to higher overall mortality in the low-cholesterol group, as in our experience cancer mortality was independent of cholesterol level. At variance, other authors have found a relation (usually J-shaped) between serum cholesterol and mortality in elderly subjects, 65 but their study was not population-based.
In conclusion, elderly subjects have a different cardiovascular risk pattern compared with younger people. Of course, age is the main risk factor and the main absolute predictor of mortality in such subjects. When relative risk is considered, arterial hypertension is a weak predictor and hypercholesterolaemia (which is of paramount importance in the young adult) plays no predictive role in the elderly. 'Minor' risk factors (uricaemia, reduced pulmonary function, tachycardia, and proteinuria), do have the strongest predictive value in the elderly. In the very old the predictors are even less numerous, and BP is not a predictor at all. An explanation for this may be that elderly persons are the survivors 66 of a population where a significant mortality due to hypertension-related complications has already made its mark, eliminating those having the worst risk pattern. The two genders have a different pattern: pulse pressure and murmurs at the neck are specially predictive in women, historical heart failure, proteinuria, tachycardia and triglycerides in men. The definition of the risk profile in the elderly is mainly based on clinical history, on physical examination (neck, chest), on electrocardiogram and on a simple
